Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

GANAXOLONE vs GANCICLOVIR: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

GANAXOLONE vs GANCICLOVIR: Safety Overview

Metric GANAXOLONE GANCICLOVIR
Total FAERS Reports 513 4,990
Deaths Reported 13 1,469
Death Rate 2.5% 29.4%
Hospitalizations 82 1,735
Average Patient Age 12.7 yrs 41.7 yrs
% Female Patients 72.7% 41.5%
FDA Approval Date Jun 1, 2022 Dec 12, 1997
Manufacturer Immedica Pharma US Inc Pharmascience Inc.
Route ORAL INTRAVENOUS
Marketing Status Prescription Discontinued